Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
---|
09/19/2012 | EP2498803A2 Factor viii t cell epitope variants having reduced immunogenicity |
09/19/2012 | EP2498802A1 Pharmaceutical composition comprising a glp-1 agonist, an insulin, and methionine |
09/19/2012 | EP2498801A1 Pharmaceutical composition comprising a glp-1 agonist and methionine |
09/19/2012 | EP2498800A1 Long-acting y2 receptor agonists |
09/19/2012 | EP2498799A1 Use of fgfr1 extra cellular domain proteins to treat cancers characterized by ligand-dependent activating mutations in fgfr2 |
09/19/2012 | EP2498798A1 Compositions and methods for wound treatment |
09/19/2012 | EP2498797A2 Treatment of heart disease |
09/19/2012 | EP2498796A2 Treatment of heart disease |
09/19/2012 | EP2498795A2 Granulysin in immunotherapy |
09/19/2012 | EP2498794A1 Method of treatment of type 2 diabetes |
09/19/2012 | EP2498793A1 Use of peptide epoxyketones for metastasis suppression |
09/19/2012 | EP2498773A2 Compositions for the treatment of chemoresistant leukaemia and/or of potentially chemoresistant leukaemia |
09/19/2012 | CN1914336B Genes associated with canine osteoarthritis and related methods and compositions |
09/19/2012 | CN1607006B Therapeutic application of chimeric and radiolabeled antibodies to human B lymphocyte restricted differentiation antigen for treatment of B cell lymphoma |
09/19/2012 | CN102686720A Method for inducing differentiation of dental pulp cells into odontoblasts |
09/19/2012 | CN102686611A Polypeptides for binding to the "receptor for advanced glycation endproducts" as well as compositions and methods involving the same |
09/19/2012 | CN102686601A Process for the synthesis of Ac-Arg-Cyclo(Cys-D-Ala-His-D-Phe-Arg-Trp-Cys)-NH2 |
09/19/2012 | CN102686243A Polymeric systems for the delivery of anticancer agents |
09/19/2012 | CN102686237A Compositions and methods for treating gaucher disease |
09/19/2012 | CN102686236A Preventative agent and/or therapeutic agent and/or exacerbation-suppressing agent for human knee osteoarthritis |
09/19/2012 | CN102686235A Depot systems comprising glatiramer or a pharmacologically acceptable salt thereof |
09/19/2012 | CN102686234A Composition for improving brain function and method for improving brain function |
09/19/2012 | CN102686226A Injectable combination of adrenergic receptor agonists with fillers, for decreasing skin reactions due to injection |
09/19/2012 | CN102676621A Antihypertensive rapeseed peptide and preparation method and application of antihypertensive rapeseed peptide |
09/19/2012 | CN102676563A Method for preparing human serum albumin-human parathyroid hormone |
09/19/2012 | CN102676535A Gene of zebra fish tumor necrosis factor 14 and cloning method and restructuring application thereof |
09/19/2012 | CN102676490A Lywallzyme of phage of staphylococcus aureus as well as preparation method and application thereof |
09/19/2012 | CN102675624A Polymer-modified protoheme and method for preparing same |
09/19/2012 | CN102675470A SCF (Stem Cell Factor)-Fc fusion protein |
09/19/2012 | CN102675464A Co-immobilized cytokine, preparation method and applications thereof |
09/19/2012 | CN102675453A Adrenocorticotrophic hormone (ACTH) analogue, preparation method and application thereof |
09/19/2012 | CN102675452A Human insulin/analogue conjugate with continuous blood sugar reduction function and high rate of combination with receptor |
09/19/2012 | CN102675451A Method for preparing hepatocyte growth-promoting factors for injection |
09/19/2012 | CN102675449A Deletion form human keratinocyte growth factor-I disulfide bond mutation form and use thereof |
09/19/2012 | CN102675431A Antitumor antibiotic gaddie mycin generated by streptosporangium C-3560 |
09/19/2012 | CN102675429A Virus capping system polypeptide inhibitor for controlling coronavirus |
09/19/2012 | CN102675428A Liver targeting cell-penetrating antiviral fusion polypeptide as well as coding gene and application thereof |
09/19/2012 | CN102675424A Polypeptide drug for resisting Hepatitis B virus X protein |
09/19/2012 | CN102675423A Polypeptide medicine against hepatitis B virus X protein |
09/19/2012 | CN102675422A Polypeptide drug against hepatitis B virus X protein (HBx) |
09/19/2012 | CN102675421A Epitope peptide of heat shock protein and application thereof |
09/19/2012 | CN102675420A Synthetic decapeptide and method for promoting generation of fish yolk |
09/19/2012 | CN102675419A Abeta oligopeptide polymerization inhibitor and preparation and application thereof |
09/19/2012 | CN102675418A Luteinizing hormone-releasing hormone (LHRH) antagonist derivative, preparation method of LHRH antagonist derivative and application of LHRH antagonist derivative |
09/19/2012 | CN102675417A Monocyte migration inhibition factor analogue, synthesis thereof and application thereof |
09/19/2012 | CN102675416A Beta-carboline derivatives, and preparation method and application thereof |
09/19/2012 | CN102675414A Method for removing/inactivating prion in glycoprotein |
09/19/2012 | CN102675279A Thiophene analogues for the treatment or prevention of flavivirus infections |
09/19/2012 | CN102674531A Water-clarifying liver-protecting compound preparation for tilapia aquiculture |
09/19/2012 | CN102671191A Composition with high dose of chondroitin sulfuric acid and method for treating type 2 diabetes mellitus |
09/19/2012 | CN102671190A Enzymic preparations for improving human body immunity and enhancing gastrointestinal and respiratory functions |
09/19/2012 | CN102671189A Iron protein succinylate solubilizing method and oral solution preparation thereof |
09/19/2012 | CN102671188A Composition containing collagen protein |
09/19/2012 | CN102671187A Application of LECT2 protein in preparation of antiviral drugs |
09/19/2012 | CN102671186A Hematopoiesis-promoting medicine combination and application thereof |
09/19/2012 | CN102671185A Application of scolopendra mutilans neurotoxin peptide omega-SLPTX-Ssmla |
09/19/2012 | CN102671184A Application of marine fish polypeptide in preparing eye drops for relieving asthenopia |
09/19/2012 | CN102671183A Superantigen protein medicine for treating orthopedic diseases |
09/19/2012 | CN102671182A Degarelix-containing medicinal composition for nasal delivery and preparation method thereof |
09/19/2012 | CN102671181A High purity lipopeptides, lipopeptide micelles and processes for preparing same |
09/19/2012 | CN102670677A New application of traditional Chinese medicine fennel |
09/19/2012 | CN102670632A Medical application of pirfenidone in inhibition of skin scar formation |
09/19/2012 | CN102670523A Method for preparing injection reduced glutathione freeze-dried powder |
09/19/2012 | CN102670522A Pharmaceutical preparation containing recombinant human serum albumin-human granulocyte colony stimulating factor fusion protein and preparation thereof |
09/19/2012 | CN102670428A Preparation method and applications for cyclodextrin collagen tripeptide inclusion complex water solution |
09/19/2012 | CN102669648A Health food for alleviating eye fatigue and preparation method thereof |
09/19/2012 | CN102060928B Bombesin-oriented anti-tumor polypeptide and preparation method and application thereof |
09/19/2012 | CN101947309B Human basic fibroblast growth factor eye drops and preparation method thereof |
09/19/2012 | CN101945648B Pharmaceutical formulation containing choline alfoscerate |
09/19/2012 | CN101906142B Carboline carboxylic acid-tetrapeptide conjugate and synthesis method as well as medical application thereof |
09/19/2012 | CN101815505B Virosomes comprising hemagglutinin derived from an influenza virus produced in a cell line, compositions, methods of manufacturing, use thereof |
09/19/2012 | CN101698103B Medicine composite for treating B type diabetes |
09/19/2012 | CN101601858B Application of midkine protein and medical device containing protein |
09/19/2012 | CN101027077B Ejection liquid, ejection device, ejection cartridge, and method of making droplets from liquid |
09/18/2012 | US8268986 RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA) |
09/18/2012 | US8268979 Human MutY |
09/18/2012 | US8268976 Flea GABA receptor subunit nucleic acid molecules |
09/18/2012 | US8268974 Taking unfolded globular protein denaturing and refolding; generating vaccine against viral capsid protein; targeting vaccine to toll-like receptor; treating cancer |
09/18/2012 | US8268967 Glycopegylated interferon α |
09/18/2012 | US8268964 MHC peptide complexes and uses thereof in infectious diseases |
09/18/2012 | US8268961 Antibacterial peptides and analogues thereof |
09/18/2012 | US8268789 PAR-2 antagonists |
09/18/2012 | US8268788 Combination cancer immunotherapy with co-stimulatory molecules |
09/18/2012 | US8268786 Anti-cancer tocotrienol analogues and associated methods |
09/18/2012 | US8268785 Use of a Pde 5 inhibitor for treating and preventing hypopigmentary disorders |
09/18/2012 | US8268784 Neuropeptide-2 receptor (Y-2R) agonists and uses thereof |
09/18/2012 | US8268783 Antidotes for factor Xa inhibitors and methods of using the same |
09/18/2012 | US8268782 Composition and method for preparing plasminogen |
09/18/2012 | US8268780 Process for solubilizing glucagon-like peptide 1 compounds |
09/18/2012 | US8268779 Pharmaceutical composition comprising oxyntomodulin derivatives and a method for reducing body weight using the composition |
09/18/2012 | US8268778 Flavivirus NS5A proteins for the treatment of HIV |
09/18/2012 | US8268777 Oximyl macrocyclic derivatives |
09/18/2012 | US8268776 mixture of cytochrome P450 monooxygenase inhibitor and protease inhibitor for anti-hepatitis C viral treatment; including other active drugs as interferon, ribavarin, and adamantine |
09/18/2012 | US8268775 Macrolactone derivatives |
09/18/2012 | US8268774 Method for reducing pain |
09/18/2012 | US8268773 Methods of treating multiple sclerosis (MS) using an IL-17A and IL-17F antagonist |
09/18/2012 | US8268618 Repressing endogenous CCR5 gene expression in cells using engineered zinc finger proteins |
09/18/2012 | US8268591 Compositions and methods for producing inhibitors of vascular endothelial growth factor activity |
09/18/2012 | US8268576 Diagnosis of autism |
09/18/2012 | US8268566 Enhanced FC receptor-mediated tumor necrosis factor superfamily MRNA expression in peripheral blood leukocytes in patients with rheumatoid arthritis |